Pharmaceuticals (维升药业) IPO: Valuation and Book Building
Visen Pharmaceuticals seeks to raise $100m for Hong Kong listing. We think the valuation is extremely inflated with tones turning bearing in the...
286 Views
Visen Pharmaceuticals (维升药业) IPO: PHIP Updates Don't Look Positive
Visen Pharmaceuticals plans to raise up to USD 300m for a Hong Kong listing. We look at changes to prospectus, which don't make the company look...
573 Views
Pre-IPO VISEN Pharmaceuticals (PHIP Updates) - Some Points Worth the Attention
Concerns arise over VISEN's R&D capabilities, facing challenges in a competitive market with potential price system disruption and limited market...
536 Views
Visen Pharmaceuticals IPO: Unfavorable Trends
Visen Pharmaceuticals plans to raise $300m for a Hong Kong listing, but concerns about their core product and unfavorable trends make us not keen...
536 Views
ECM Weekly (24th Mar 2025) -JX Advance, DN Solutions, Nanshan Aluminimum, Anthem, EAAA, Judo Capital
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
250 Views